What is Levodopa Market?
Levodopa, also known as L-Dopa, an aromatic amino acid which is used in combination with carbidopa in treatment for Parkinsonís symptoms and also associated with other diseases. Moreover, it can be used at all stages of Parkinsonís diseases. Every year approximately 60,000 people in America are diagnosed with Parkinsonís disease, as per Parkinson Association of the Carolinas. In addition, globally around 7 to 10 million people are subjected to Parkinsonís disease.
The market study is being classified, by Application (Pharmaceuticals Industry and Dietary Supplements) and major geographies with country level break-up.
Teva Pharmaceutical (Israel), Taj Pharmaceuticals (India), Guangzhou Hanfang Pharmaceutical (China), Guangxi Hefeng Pharmaceutical (China), Xi'an Lyphar Biotech (China), Hindustan Herbals (India), Xi'an ZB Biotech (China), Xi'an Arisun ChemPharm (China) and Hunan Nutramax (China) are some of the key players profiled in the study.
Research Analyst at AMA predicts that Chinese Players will contribute to the maximum growth of Global Levodopa market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Levodopa market by Type, Application and Region.
On the basis of geography, the market of Levodopa has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Growth in Ageing Population and the Associated Increase in the Prevalence of Parkinsonís Disease
- Government Funding for Research And Development
- Increasing Incidence Rate of Parkinson's Disease in the Developed Countries
- Availability of Alternative Treatments
- Lack of Awareness in Underdeveloped Nations
- Patent Expiry of Branded Drugs
- Strong Pipeline
- Increase in Awareness About Parkinsonís Disease
- High Cost of Treatment and Medicines
Key Target AudienceLevodopa Disease Treatment Product Manufacturers, Levodopa Disease Treatment Dealers and Suppliers, Human Identification Service Providers, Levodopa Disease Associations, Academic Institutions, Government Organizations and Others